ArticleClinical and translational radiation oncology2022

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer.

Lynsey Devlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.